Kaposi's Sarcoma-Associated Herpesvirus LANA2 Is a B-Cell-Specific Latent Viral Protein That Inhibits p53
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Kaposi's sarcoma-associated herpesvirus (KSHV), or human herpesvirus 8, is associated with three proliferative diseases ranging from viral cytokine-induced hyperplasia to monoclonal neoplasia: multicentric Castleman's disease (CD), Kaposi's sarcoma (KS), and primary effusion lymphoma (PEL). Here we report a new latency-associated 1,704-bp KSHV spliced gene belonging to a cluster of KSHV sequences having homology to the interferon regulatory factor (IRF) family of transcription factors. ORFK10.5 encodes a protein, latency-associated nuclear antigen 2 (LANA2), which is expressed in KSHV-infected hematopoietic tissues, including PEL and CD but not KS lesions. LANA2 is abundantly expressed in the nuclei of cultured KSHV-infected B cells. Transcription of K10.5 in PEL cell cultures is not inhibited by DNA polymerase inhibitors nor significantly induced by phorbol ester treatment. Unlike LANA1, LANA2 does not elicit a serologic response from patients with KS, PEL, or CD as measured by Western blot hybridization. Both KSHV vIRF1 (ORFK9) and LANA2 (ORFK10.5) appear to have arisen through gene duplication of a captured cellular IRF gene. LANA2 is a potent inhibitor of p53-induced transcription in reporter assays. LANA2 antagonizes apoptosis due to p53 overexpression in p53-null SAOS-2 cells and apoptosis due to doxorubicin treatment of wild-type p53 U2OS cells. While LANA2 specifically interacts with amino acids 290 to 393 of p53 in glutathione S -transferase pull-down assays, we were unable to demonstrate LANA2-p53 interaction in vivo by immunoprecipitation. These findings show that KSHV has tissue-specific latent gene expression programs and identify a new latent protein which may contribute to KSHV tumorigenesis in hematopoietic tissues via p53 inhibition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Jayachandra, S., Low, K. G., Thlick, A.-E., Yu, J. C., Ling, P. D., Chang, Y., & Moore, P. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11566 · Cited by 104
Self-citationRetractedCesarman, E., Chang, Y., Moore, P. S., Said, J. W., & Knowles, D. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321802 · Cited by 2,818
Self-citationRequirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Guan, K., & Dixon, J. E. (1991) · Analytical Biochemistry · doi:10.1016/0003-2697(91)90534-z · Cited by 1,746
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
Russo, J. J., Bohenzky, R. A., Chien, M.-C., Chen, J., Yan, M., Maddalena, D., Parry, J. P., Peruzzi, D., Edelman, I. S., Chang, Y., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14862 · Cited by 1,467
Self-citationTakebe, Y., Seiki, M., Fujisawa, J.-I., Hoy, P., Yokota, K., Arai, K.-I., Yoshida, M., & Arai, N. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.1.466-472.1988 · Cited by 1,330
Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV
Moore, P. S., Boshoff, C., Weiss, R. A., & Chang, Y. (1996) · Science · doi:10.1126/science.274.5293.1739 · Cited by 904
Self-citationBais, C., Santomasso, B., Coso, O., Arvanitakis, L., Raaka, E. G., Gutkind, J. S., Asch, A. S., Cesarman, E., Gerhengorn, M. C., & Mesri, E. A. (1998) · Nature · doi:10.1038/34193 · Cited by 829
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
Gao, S.-J., Kingsley, L., Li, M., Zheng, W., Parravicini, C., Ziegler, J., Newton, R., Rinaldo, C. R., Saah, A., Phair, J., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-925 · Cited by 799
Self-citationKedes, D. H., Operskalski, E., Busch, M., Kohn, R., Flood, J., & Ganem, D. (1996) · Nature Medicine · doi:10.1038/nm0896-918 · Cited by 751
p53 inhibition by the LANA protein of KSHV protects against cell death
Friborg, J., Kong, W.-P., Hottiger, M. O., & Nabel, G. J. (1999) · Nature · doi:10.1038/47266 · Cited by 704
Efficient Persistence of Extrachromosomal KSHV DNA Mediated by Latency-Associated Nuclear Antigen
Ballestas, M. E., Chatis, P. A., & Kaye, K. M. (1999) · Science · doi:10.1126/science.284.5414.641 · Cited by 694
SUMO-1 modification activates the transcriptional response of p53
Rodriguez, M. S., Desterro, J. M. P., Lain, S., Midgley, C. A., Lane, D. P., & Hay, R. T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.22.6455 · Cited by 639
Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., & Taniguchi, T. (1994) · Cell · doi:10.1016/0092-8674(94)90132-5 · Cited by 491
A Cluster of Latently Expressed Genes in Kaposi’s Sarcoma-Associated Herpesvirus
Dittmer, D. P., Lagunoff, M., Renne, R., Staskus, K., Haase, A. T., & Ganem, D. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8309-8315.1998 · Cited by 443
Sarid, R., Flore, O., Bohenzky, R. A., Chang, Y., & Moore, P. S. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1005-1012.1998 · Cited by 438
Self-citationKinetics of Kaposi’s Sarcoma-Associated Herpesvirus Gene Expression
Sun, R., Lin, S.-F., Staskus, K., Gradoville, L., Grogan, E., Haase, A., & Miller, G. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2232-2242.1999 · Cited by 404
Neipel, F., Albrecht, J. C., & Fleckenstein, B. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4187-4192.1997 · Cited by 402
KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway
Gao, S.-J., Boshoff, C., Jayachandra, S., Weiss, R. A., Chang, Y., & Moore, P. S. (1997) · Oncogene · doi:10.1038/sj.onc.1201571 · Cited by 356
Self-citationKaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue
Sarid, R., Sato, T., Bohenzky, R. A., Russo, J. J., & Chang, Y. (1997) · Nature Medicine · doi:10.1038/nm0397-293 · Cited by 352
Self-citationCyclin encoded by KS herpesvirus
Chang, Y., Moore, P. S., Talbot, S. J., Boshoff, C. H., Zarkowska, T., Godden-Kent, D., Paterson, H., Weiss, R. A., & Mittnacht, S. (1996) · Nature · doi:10.1038/382410a0 · Cited by 341
Self-citationDeregulation of cell growth by the K1 gene of Karposi's sarcoma-associated herpesvirus
Lee, H., Veazey, R., Williams, K., Li, M., Guo, J., Neipel, F., Fleckenstein, B., Lackner, A., Desrosiers, R. C., & Jung, J. U. (1998) · Nature Medicine · doi:10.1038/nm0498-435 · Cited by 294
Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin
Li, M., Lee, H., Yoon, D. W., Albrecht, J. C., Fleckenstein, B., Neipel, F., & Jung, J. U. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.1984-1991.1997 · Cited by 292
Godden-Kent, D., Talbot, S. J., Boshoff, C., Chang, Y., Moore, P., Weiss, R. A., & Mittnacht, S. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4193-4198.1997 · Cited by 288
Self-citationKatano, H., Sato, Y., Kurata, T., Mori, S., & Sata, T. (2000) · Virology · doi:10.1006/viro.2000.0196 · Cited by 250
Epstein-Barr virus strategy in normal and neoplastic B cells
Klein, G. (1994) · Cell · doi:10.1016/0092-8674(94)90125-2 · Cited by 244
Zimring, J. C., Goodbourn, S., & Offermann, M. K. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.701-707.1998 · Cited by 215
Burýšek, L., Yeow, W.-S., Lubyová, B., Kellum, M., Schafer, S. L., Huang, Y. Q., & Pitha, P. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7334-7342.1999 · Cited by 214
Kaposi’s Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor
Li, M., Lee, H., Guo, J., Neipel, F., Ozato, K., Jung, J. U., Fleckenstein, B., Jae, & Jung, U. (1997) · Cited by 171
Talbot, S. J., Weiss, R. A., Kellam, P., & Boshoff, C. (1999) · Virology · doi:10.1006/viro.1999.9672 · Cited by 156
Kaposi’s Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor
Li, M., Lee, H., Guo, J., Neipel, F., Fleckenstein, B., Ozato, K., & Jung, J. U. (1998) · Journal of Virology · doi:10.1128/jvi.72.7.5433-5440.1998 · Cited by 151
Ojala, P. M., Tiainen, M., Salvén, P., Veikkola, T., Castaños‐Vélez, E., Sarid, R., Biberfeld, P., & Mäkelä, T. P. (1999) · PubMed · Cited by 126
Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
Burýšek, L., Yeow, W.-S., & Pitha, P. M. (1999) · PubMed · Cited by 126
High Expression of HHV-8-Encoded ORF73 Protein in Spindle-Shaped Cells of Kaposi's Sarcoma
Katano, H., Sato, Y., Kurata, T., et al. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65097-3 · Cited by 106
Flowers, C. C., Flowers, S. P., & Nabel, G. J. (1998) · Molecular Medicine · doi:10.1007/bf03401747 · Cited by 51
Cited by
Impact of Protein Kinase PKR in Cell Biology: from Antiviral to Antiproliferative Action
García, M. A., Gil, J., Ventoso, I., Guerra, S., Domingo, E., Rivas, C., & Esteban, M. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00027-06 · Cited by 818
Self-citationWhy do viruses cause cancer? Highlights of the first century of human tumour virology
Moore, P. S., & Chang, Y. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2961 · Cited by 745
Self-citationThe dsRNA protein kinase PKR: Virus and cell control
García, M. A., Meurs, E. F., & Esteban, M. (2007) · Biochimie · doi:10.1016/j.biochi.2007.03.001 · Cited by 644
Boshoff, C., & Weiss, R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc797 · Cited by 443
KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine
Ganem, D. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40567 · Cited by 385
Metadata
- Authors
- Rivas, C., Thlick, A.-E., Parravicini, C., Moore, P. S., & Chang, Y.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2001-01
- Volume
- 75
- Issue
- 1
- Pages
- 429-438
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W1990386824
- Cited by
- 296
- References
- 36
- FWCI
- 8.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.